APPLICATION
ANDA211035
TYPE
ANDA
ORIGINAL APPROVAL
2018-06-18
LATEST ACTION
2026-05-20
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 5MG/2ML (2.5MG/ML) · SOLUTION · INTRAVENOUS
VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 10MG/4ML (2.5MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2026-05-20Labeling · Supplement 1 · standardAP
2026-05-20Labeling · Supplement 11 · standardAP
2018-06-18UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.